Status:
COMPLETED
The Immersive Experience of Virtual Reality During Chemotherapy in Patients With Early Breast and Gynecological Cancers: the Patient's Dream Study
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Breast Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
"Patient's dream" study is a two-arm randomized controlled trial that will be conducted at Regina Elena National Cancer Institute, IRCCS (Rome), from April 2019 to January 2020. Before starting the fi...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- diagnosis of breast or ovarian cancer confirmed histologically, from I to III stage;
- surgery as first therapeutic approach (in case of ovarian cancer, patients with minimal residual disease after surgery will be also included)
- first cycle of adjuvant CT, with or without a biological treatment according to the specific cancer (regimens including anthracyclines/taxanes, anthracyclines/cyclophosphamide, carboplatinum/taxane combined or not with trastuzumab for breast cancer, carboplatin/paclitaxel combined or not with bevacizumab for ovarian cancer);
- aged ≥ 18 years;
- performance status (ECOG) 0-2;
- life expectancy \> 12 months;
- ability to understand and sign the informed consent.
- Exclusion Criteria:
- presenting prior history of seizures;
- disorders of the mood;
- previous history of alcohol and/or drug addiction;
- disorder of vision and eyes;
- history of psychiatric pathologies.
Exclusion
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05234996
Start Date
April 1 2019
End Date
April 1 2021
Last Update
February 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
alessandra Fabi
Roma, Italy, 00164